ArticleScientific reports2025
Genetic evidence suggests a causal relationship linking thyroid function to prospective memory and dementia and Parkinson's disease.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Hyperthyroidism Is Genetically Associated With Reduced Risk of Parkinson's Disease: A Mendelian Randomization Analysis.The European journal of neuroscience · 2026Article
- Modifiable and clinically actionable exposures for vascular dementia: a structured evidence synthesis of Mendelian randomization studies.Journal of neurology · 2026Review
- Global research trends on thyroid hormones and neurodegenerative diseases: a bibliometric study from 2015 to 2025.Frontiers in aging neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Epidemiological studies suggest a link between thyroid function and prospective memory (PM), but more evidence is required. We used a two-sample Mendelian randomization (MR) study to explore this. Utilizing data from genome-wide association studies, the exposures included thyroid cancer (TC), thyroid-stimulating hormone (TSH), hypothyroidism, hyperthyroidism (HT), and radiation (RAD), while the outcome variables consisted of PM, Parkinson's disease (PD) and four dementia subtypes: Alzheimer's disease (AD), Lewy body dementia (DLB), frontotemporal dementia (FTD), and vascular dementia (VD). The inverse-variance weighted (IVW) method was the primary MR analysis. Heterogeneity testing and sensitivity analyses affirmed the robustness of the MR results. TSH was causally linked to PD [OR = 0.811, 95% CI = 0.692-0.951, p = 0.010]. Hypothyroidism was causally associated with AD and DLB [AD OR = 0.954, 95% CI = 0.916-0.993, p = 0.022; DLB OR = 0.845, 95% CI = 0.745-0.959, p = 0.009]. There might be a causal relationship between hypothyroidism and both PD and PM, while HT might influence PM. TC and RAD showed no causal relationship with PM, PD and dementia. TSH serves as a protective factor against PD, while hypothyroidism is a protective factor against AD and DLB. Hypothyroidism may pose a risk for PM deficits and PD, whereas HT may be a risk factor for PM. Additionally, TC and RAD does not appear to cause damage to PM, PD and increase dementia risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.